This content is from: Corporate

US lawsuit could force Chinese sovereign immunity changes

The referral of a US investment fund’s Hong Kong lawsuit to Beijing has prompted calls for China to amend its position on sovereign immunity

To access our in-house intelligence please request a trial here.

Read this article – and more – for a 30 day period.


Are you already an IFLR subscriber? Login here

Instant access to all of our content. Membership Options | 30 Day Trial